DK534281A - Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater - Google Patents

Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater

Info

Publication number
DK534281A
DK534281A DK564281A DK534281A DK534281A DK 534281 A DK534281 A DK 534281A DK 564281 A DK564281 A DK 564281A DK 534281 A DK534281 A DK 534281A DK 534281 A DK534281 A DK 534281A
Authority
DK
Denmark
Prior art keywords
oxozetime
ingrediates
sulfo
preparing
procedure
Prior art date
Application number
DK564281A
Other languages
Danish (da)
English (en)
Inventor
T Matsuno
H Masuya
N Noguchi
M Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK534281A publication Critical patent/DK534281A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK564281A 1980-12-03 1981-12-02 Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater DK534281A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1980/000293 WO1982001871A1 (en) 1980-12-03 1980-12-03 Process for preparing a 1-sulfo-2-oxoazetidine derivative

Publications (1)

Publication Number Publication Date
DK534281A true DK534281A (da) 1982-06-04

Family

ID=13706129

Family Applications (1)

Application Number Title Priority Date Filing Date
DK564281A DK534281A (da) 1980-12-03 1981-12-02 Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater

Country Status (5)

Country Link
EP (1) EP0053387A1 (de)
JP (1) JPS57118560A (de)
DK (1) DK534281A (de)
ES (1) ES8303327A1 (de)
WO (1) WO1982001871A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0053387A1 (de) 1982-06-09
WO1982001871A1 (en) 1982-06-10
ES507638A0 (es) 1983-02-01
JPS57118560A (en) 1982-07-23
ES8303327A1 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK52381A (da) Fremgangsmaade til fremstilling af betalactamer
DK525481A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK354281A (da) Fremgangsmaade til geninkorporering af kakaoaroma
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK489381A (da) Fremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK115581A (da) Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK142381A (da) Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser
DK226881A (da) Fremgangsmaade til fremstilling af 3-picolin
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da) Fremgangsmade til fremstilling af n-phosphonometylglycin
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner
DK362381A (da) Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser
DK57881A (da) Fremgangsmaade til fremstilling af benzylinderivater
DK159417C (da) Fremgangsmaade til fremstilling af alfa-ketocarboxylsyre-n-tert.butylamider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment